文献速递神经重症神经肿瘤

地塞米松给药与脑脓肿患者死亡率:系统评价与Meta分析

Dexamethasone Administration and Mortality in Patients with Brain Abscess: A Systematic Review and Meta-Analysis.
PubMed 文献 · World Neurosurg · 2018-04-26

该系统评价与Meta分析检索PubMed、Embase和Cochrane数据库,纳入11项研究(7项队列研究、4项病例系列),其中7项队列研究共571例脑脓肿患者(330例接受标准治疗联合地塞米松,241例仅接受标准治疗)。汇总分析显示,与仅接受标准治疗相比,联合地塞米松的患者死亡率无显著获益(固定效应模型RR 0.94,95%CI 0.64-1.37;I²=53.9%,异质性P=0.04)。结论认为,在接受抗生素治疗的脑脓肿患者中,使用地塞米松与死亡率增加无关。

要点

  • 7项队列研究共571例脑脓肿患者,330例接受标准治疗联合地塞米松,241例仅接受标准治疗。
  • 联合地塞米松与仅标准治疗相比,死亡率无显著差异(固定效应模型RR 0.94,95%CI 0.64-1.37)。

核心结论

  • 在接受抗生素治疗的脑脓肿患者中,使用地塞米松与死亡率增加无关。

研究设计与样本

  • 系统评价与Meta分析,遵循PRISMA指南,检索PubMed、Embase和Cochrane数据库,最终纳入11项研究(7项队列研究和4项病例系列)。
  • 7项队列研究共纳入571例脑脓肿患者,其中330例接受标准治疗联合地塞米松,241例仅接受标准治疗;两组均在脓肿穿刺抽吸或手术治疗后给药。
  • 给予地塞米松的指征为医院脑脓肿方案或临床表现为脑水肿。

主要发现

  • 7项队列研究汇总显示,与仅接受标准治疗相比,联合地塞米松的患者死亡率无显著获益(固定效应模型RR 0.94,95%CI 0.64-1.37)。

局限性

  • 异质性I²=53.9%(异质性检验P=0.04)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dexamethasone has been used to treat cerebral edema associated with brain abscess. Whereas some argue that dexamethasone might aid antibiotic treatment, others believe that because of its immunosuppressive characteristics, it might have a negative impact on outcomes. How corticosteroid use affects overall mortality of brain abscess patients remains unclear. METHODS: A systematic search of the literature was conducted in accordance with PRISMA guidelines. PubMed, Embase, and Cochrane databases were utilized to identify all studies related to patients diagnosed with a brain abscess treated with dexamethasone. The main outcome of interest was mortality. Pooled effect estimates were calculated using fixed-effects (FE) and random-effects (RE) models. RESULTS: After removal of duplicates, 1681 articles were extracted from the literature of which 11 were included. These included 7 cohort studies and 4 case series. Indications to administer dexamethasone were either hospital brain abscess protocol or clinical presentation of cerebral edema. The 7 cohort studies involving 571 patients with brain abscesses comprised of 330 patients treated with standard of care (SOC) plus dexamethasone and 241 patients treated with SOC alone, after aspiration or surgical management of the abscess in either group. Pooling results from all seven cohort studies demonstrated a nonsignificant mortality benefit comparing SOC and dexamethasone patients to SOC patients (FE: risk ratio [RR], 0.94; 95% confidence interval [CI], 0.64-1.37; RE: RR, 0.95; 95% CI, 049-1.82; I2 = 53.9%; P for heterogeneity = 0.04). CONCLUSIONS: In patients with a brain abscess treated with antibiotics, the use of dexamethasone was not associated with increased mortality.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Simjian T, Muskens IS, Lamba N, et al. Dexamethasone Administration and Mortality in Patients with Brain Abscess: A Systematic Review and Meta-Analysis. World Neurosurg. 2018. PMID: 29705232. doi:10.1016/j.wneu.2018.04.130

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。